Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Riley

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Plos Biology|February 4, 2010
Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1Shoba Amarnath, Carliann M Costanzo, Jacopo Mariotti, et al.
The American Journal of Pathology|January 10, 2014
The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4(+) T lymphocytesQian Zhang, Fang Wei, Hong Yi Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 14, 2014
Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent mannerQian Zhang, Hong Yi Wang, Fang Wei, et al.
Blood Advances|February 10, 2023
Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stabilityZhenguo Zi, Shujuan Du, Liming Zhang, et al.
Virology|December 31, 2002
DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cellsGraham Simmons, Jacqueline D Reeves, Case C Grogan, et al.
Cancer Immunology Research|April 29, 2025
CAR Binders Affect CAR T-cell Tonic Signaling, Durability, and Sensitivity to TargetDivanshu Shukla, Khatuna Gabunia, Shannon E McGettigan, et al.
Journal for Immunotherapy of Cancer|January 9, 2026
Engineering single-vector logic-gated CAR T cells with transgene sizes beyond current limitationsPhilipp C Rommel, Nils W Engel, Julia K Malachowski, et al.
Cancer Immunology Research|August 30, 2023
Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and FunctionCaimei Zhang, Siddhant Kadu, Yansen Xiao, et al.
Immunologic Research|October 25, 2008
Adoptive immunotherapy: good habits instilled at youth have long-term benefitsChrystal M Paulos, Megan M Suhoski, Gabriela Plesa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2009
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivoMichael C Milone, Jonathan D Fish, Carmine Carpenito, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Plos Biology|February 4, 2010
Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1Shoba Amarnath, Carliann M Costanzo, Jacopo Mariotti, et al.
The American Journal of Pathology|January 10, 2014
The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4(+) T lymphocytesQian Zhang, Fang Wei, Hong Yi Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 14, 2014
Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent mannerQian Zhang, Hong Yi Wang, Fang Wei, et al.
Blood Advances|February 10, 2023
Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stabilityZhenguo Zi, Shujuan Du, Liming Zhang, et al.
Virology|December 31, 2002
DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cellsGraham Simmons, Jacqueline D Reeves, Case C Grogan, et al.
Cancer Immunology Research|April 29, 2025
CAR Binders Affect CAR T-cell Tonic Signaling, Durability, and Sensitivity to TargetDivanshu Shukla, Khatuna Gabunia, Shannon E McGettigan, et al.
Journal for Immunotherapy of Cancer|January 9, 2026
Engineering single-vector logic-gated CAR T cells with transgene sizes beyond current limitationsPhilipp C Rommel, Nils W Engel, Julia K Malachowski, et al.
Cancer Immunology Research|August 30, 2023
Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and FunctionCaimei Zhang, Siddhant Kadu, Yansen Xiao, et al.
Immunologic Research|October 25, 2008
Adoptive immunotherapy: good habits instilled at youth have long-term benefitsChrystal M Paulos, Megan M Suhoski, Gabriela Plesa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2009
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivoMichael C Milone, Jonathan D Fish, Carmine Carpenito, et al.
Pageof 13